The measles-mumps-rubella vaccination in children with juvenile idiopathic arthritis compared with no booster did not result in worsened juvenile idiopathic arthritis disease activity and was immunogenic, according to recent study findings published in The Journal of the American Medical Association.
“Patients with [juvenile idiopathic arthritis] may be susceptible to infections through the immunosuppressive effect of their disease or its treatment,” researchers wrote. “Preventing infections in patients with [juvenile idiopathic arthritis] requires effective and safe vaccinations that induce protective immune responses, have no severe adverse effects, and do not affect [juvenile idiopathic arthritis] disease activity.”
Full Story »
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.